Skip to content

Topic

pharmaceuticals

25 markets across Kalshi and Polymarket, $2K traded today.

MarketChance24hBest priceVolume 24h
FDA decision: Bepirovirsen by GlaxoSmithKline (in 2026)EconomicsEnds Dec 31, 202689%—Kalshi92¢$703
Will the FDA approve any psychedelic substance for medical use this year?Tech & ScienceEnds Dec 31, 202626%—Kalshi29¢$554
FDA decision: Ifinatamab Deruxtecan by Daiichi Sankyo (in 2026)EconomicsEnds Dec 31, 202684%—Kalshi87¢$495
What will Johnson & Johnson say during their next earnings call?LitigationCultureEnds Mar 31, 202782%—Kalshi86¢$131
FDA decision: Ivonescimab by Summit Therapeutics (in 2026)EconomicsEnds Dec 31, 202685%—Kalshi88¢$28
Will the FDA approve cytisinicline for smoking cessation?Before Jan 1, 2027Tech & ScienceEnds Sep 30, 202614%—Kalshi18¢$20
When will the FDA approve Compass Pathways' COMP360 Psilocybin?Before Jan 1, 2027Tech & ScienceEnds Dec 31, 202636%—Kalshi39¢$12
When will the FDA approve Intellia Therapeutics' lonvo-z?Before July 2027Tech & ScienceEnds Jun 30, 202788%—Kalshi92¢$10
Merck & Moderna merger/acquisition announced in 2026?OtherEnds Dec 31, 202619%—Polymarket35.9¢$7
When will Beam Therapeutics submit a BLA for Risto-cel?before 2027Tech & ScienceEnds Sep 1, 202659%—Kalshi62¢$2
When will Compass Pathways submit a NDA for COMP360 psilocybin?before 2027Tech & ScienceEnds Sep 1, 202675%—Kalshi78¢$0
Which peptides will the FDA propose adding to the 503A Bulks List?EpitalonPoliticsEnds Sep 30, 202777%—Kalshi79¢—
Will the FDA approve retatrutide?Before Jan 1, 2029Tech & ScienceEnds Dec 31, 202696%—Kalshi99¢—
BrightSpring Health prescriptions filled in Q3Above 10.65 millionEconomicsEnds Mar 6, 202785%—Kalshi88¢—
BrightSpring Health prescriptions filled in fiscal 2026Above 42.9 millionEconomicsEnds Jun 3, 202785%—Kalshi88¢—
Will the FDA approve CagriSema?Before Jan 1, 2028Tech & ScienceEnds Sep 30, 202681%—Kalshi84¢—
When will CMS announce the addition of GLP-1 drugs for obesity to Part D?Before Jan 1, 2028PoliticsEnds Dec 31, 202671%—Kalshi97¢—
FDA decision: Saroglitazar by Zydus Therapeutics (in 2026)EconomicsEnds Dec 31, 202677%—Kalshi80¢—
Will New Jersey pharmaceutical manufacturing jobs rise YoY?EconomicsEnds Apr 30, 20279%—Kalshi9¢—
Will North Carolina pharmaceutical manufacturing jobs rise YoY?EconomicsEnds Mar 31, 202736%—Kalshi36¢—
FDA decision: Anitocabtagene Autoleucel (anito-cel) by Gilead Sciences (in 2026)EconomicsEnds Dec 31, 202689%—Kalshi92¢—
FDA moves BPC-157 to Category 1 by…?PoliticsEnds Dec 31, 202653%—Polymarket88¢—
FDA decision: BBP-418 by Ml Bio Solutions Inc. (in 2026)EconomicsEnds Dec 31, 202691%—Kalshi93¢—
Eli Lilly licenses Peptron’s SmartDepot by October 7?EconomicsEnds Oct 6, 202613%—Polymarket13¢—
FDA decision: Venglustat by Sanofi (in 2026)EconomicsEnds Dec 31, 202682%—Kalshi85¢—